Testing the drug substitution switching-addictions hypothesis: A prospective study in a nationally representative sample

JAMA Psychiatry

Volumn 71, Issue 11, 2014, Pages 1246-1253

  Blanco, Carlos ^a   Okuda, Mayumi ^a   Wang, Shuai ^a   Liu, Shang Min ^a   Olfson, Mark ^a  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COCAINE; OPIATE;

ADULT; ALCOHOL USE DISORDER; ARTICLE; ATTENTION DEFICIT DISORDER; BIPOLAR DISORDER; CANNABIS USE; COHORT ANALYSIS; COMORBIDITY ASSESSMENT; CONTROLLED STUDY; DRUG SUBSTITUTION; DRUG USE; DSM-IV; DYSTHYMIA; FEMALE; FOLLOW UP; GENERALIZED ANXIETY DISORDER; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PANIC; PERSONALITY DISORDER; PROSPECTIVE STUDY; REMISSION; RISK FACTOR; SOCIAL PHOBIA; SUBSTANCE ABUSE; TOBACCO DEPENDENCE; COMORBIDITY; HEALTH SURVEY; MARRIAGE; MENTAL DISORDERS; ONSET AGE; RECURRENT DISEASE; SEX DIFFERENCE; SUBSTANCE-RELATED DISORDERS; UNITED STATES;

ADULT; AGE OF ONSET; COMORBIDITY; FEMALE; HEALTH SURVEYS; HUMANS; MALE; MARITAL STATUS; MENTAL DISORDERS; PROSPECTIVE STUDIES; RECURRENCE; REMISSION, SPONTANEOUS; RISK FACTORS; SEX FACTORS; SUBSTANCE-RELATED DISORDERS; UNITED STATES;

EID: 84923647729     PISSN: 2168622X     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamapsychiatry.2014.1206     Document Type: Article

References (51)

1. Compton WM, Thomas YF, Stinson FS, Grant BF. Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry. 2007;64(5):566-576.
2. Blanco C, Krueger RF, Hasin DS, et al. Mapping common psychiatric disorders: structure and predictive validity in the national epidemiologic survey on alcohol and related conditions. JAMA Psychiatry. 2013;70(2):199-208.
3. Rubio JM, Olfson M, Perez-Fuentes G, Garcia-Toro M,Wang S, Blanco C. Effect of first episode axis I disorders on quality of life. J Nerv Ment Dis. 2014;202(4):271-274.
4. Hser YI, Hoffman V, Grella CE, Anglin MD. A 33-year follow-up of narcotics addicts. Arch Gen Psychiatry. 2001;58(5):503-508.
5. Rubio JM, Olfson M, Villegas L, Perez-Fuentes G, Wang S, Blanco C. Quality of life following remission of mental disorders: findings from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry. 2013;74(5): e445-e450.
6. Sussman S, Black DS. Substitute addiction: a concern for researchers and practitioners. J Drug Educ. 2008;38(2):167-180.
7. Kendler KS, Jacobson KC, Prescott CA, Neale MC. Specificity of genetic and environmental risk factors for use and abuse/dependence of cannabis, cocaine, hallucinogens, sedatives, stimulants, and opiates in male twins. Am J Psychiatry. 2003;160 (4):687-695.
8. Peters EN, Hughes JR. Daily marijuana users with past alcohol problems increase alcohol consumption during marijuana abstinence. Drug Alcohol Depend. 2010;106(2-3):111-118.
9. Haylett SA, Stephenson GM, Lefever RM. Covariation in addictive behaviours: a study of addictive orientations using the Shorter PROMIS Questionnaire. Addict Behav. 2004;29(1):61-71.
10. Maremmani I, Pani PP, Mellini A, et al. Alcohol and cocaine use and abuse among opioid addicts engaged in amethadone maintenance treatment program. J Addict Dis. 2007;26(1):61-70.
11. RuanWJ, Goldstein RB, Chou SP, et al. The Alcohol Use Disorder and Associated Disabilities Interview Schedule-IV (AUDADIS-IV): reliability of new psychiatric diagnostic modules and risk factors in a general population sample. Drug Alcohol Depend. 2008;92(1-3):27-36.
12. Grant BF, Dawson DA, Stinson FS, Chou PS, Kay W, Pickering R. The Alcohol Use Disorder and Associated Disabilities Interview Schedule-IV (AUDADIS-IV): reliability of alcohol consumption, tobacco use, family history of depression and psychiatric diagnostic modules in a general population sample. Drug Alcohol Depend. 2003;71 (1):7-16.
13. Cottler LB, Grant BF, Blaine J, et al. Concordance of DSM-IV alcohol and drug use disorder criteria and diagnoses as measured by AUDADIS-ADR, CIDI, and SCAN. Drug Alcohol Depend. 1997;47(3):195-205.
14. Hasin DS, Goodwin RD, Stinson FS, Grant BF. Epidemiology of major depressive disorder: results from the National Epidemiologic Survey on Alcoholism and Related Conditions. Arch Gen Psychiatry. 2005;62(10):1097-1106.
15. Bernardi S, Faraone SV, Cortese S, et al. The lifetime impact of attention deficit hyperactivity disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). Psychol Med. 2012;42(4):875-887.
16. Research Triangle Institute. Software for Survey Data Analysis (SUDAAN) Language Manual, Release 10.0. Research Triangle Park, NC: Research Triangle Institute; 2008.
17. Lopez-Quintero C, Perez de los Cobos J, Hasin DS, et al. Probability and predictors of transition from first use to dependence on nicotine, alcohol, cannabis, and cocaine: results of the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). Drug Alcohol Depend. 2011; 115(1-2):120-130.
18. Lopez-Quintero C, Hasin DS, de Los Cobos JP, et al. Probability and predictors of remission from life-time nicotine, alcohol, cannabis or cocaine dependence: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Addiction. 2011;106(3):657-669.
19. Florez-Salamanca L, Secades-Villa R, Budney AJ, Garcia-Rodriguez O,Wang S, Blanco C. Probability and predictors of cannabis use disorders relapse: results of theNational Epidemiologic Survey on Alcohol and Related Conditions (NESARC). Drug Alcohol Depend. 2013;132(1-2):127-133.
20. Hasin D, Fenton MC, Skodol A, et al. Personality disorders and the 3-year course of alcohol, drug, and nicotine use disorders. Arch Gen Psychiatry. 2011;68(11):1158-1167.
21. Breslau N, Peterson E, Schultz L, Andreski P, Chilcoat H. Are smokerswith alcohol disorders less likely to quit?AmJ Public Health. 1996;86(7): 985-990.
22. Agosti V, Levin FR. Does remission from alcohol and drug use disorders increase the likelihood of smoking cessation among nicotine dependent young adults? Soc Psychiatry Psychiatr Epidemiol. 2009;44(2):120-124.
23. FillmoreMT. Drug abuse as a problem of impaired control: current approaches and findings. Behav Cogn Neurosci Rev. 2003;2(3):179-197.
24. Bradberry CW, Lee T, Jatlow P. Rapid induction of behavioral and neurochemical tolerance to cocaethylene, a model compound for agonist therapy of cocaine dependence. Psychopharmacology (Berl). 1999;146(1):87-92.
25. Conway KP, Kane RJ, Ball SA, Poling JC, Rounsaville BJ. Personality, substance of choice, and polysubstance involvement among substance dependent patients. Drug Alcohol Depend. 2003;71 (1):65-75.
26. Goodwin RD, Kim JH,Weinberger AH, Taha F, Galea S, Martins SS. Symptoms of alcohol dependence and smoking initiation and persistence: a longitudinal study among US adults. Drug Alcohol Depend. 2013;133(2):718-723.
27. Rosner S, Hackl-Herrwerth A, Leucht S, Vecchi S, Srisurapanont M, SoykaM. Opioid antagonists for alcohol dependence. Cochrane Database Syst Rev. 2010;(12):CD001867.
28. De Graaf R, Bijl RV, Ravelli A, Smit F, Vollebergh WA. Predictors of first incidence of DSM-III-R psychiatric disorders in the general population: findings from the Netherlands Mental Health Survey and Incidence Study. Acta Psychiatr Scand. 2002;106(4):303-313.
29. Grant BF, Stinson FS, Harford TC. Age at onset of alcohol use and DSM-IV alcohol abuse and dependence: a 12-year follow-up. J Subst Abuse. 2001;13(4):493-504.
30. Placzek AN, Zhang TA, Dani JA. Age dependent nicotinic influences over dopamine neuron synaptic plasticity. Biochem Pharmacol. 2009;78(7): 686-692.
31. Lappalainen J, Long JC, EggertM, et al. Linkage of antisocial alcoholism to the serotonin 5-HT1B receptor gene in 2 populations. Arch Gen Psychiatry. 1998;55(11):989-994.
32. Chamorro J, Bernardi S, Potenza MN, et al. Impulsivity in the general population: a national study. J Psychiatr Res. 2012;46(8):994-1001.
33. Taylor J. Substance use disorders and cluster B personality disorders: physiological, cognitive, and environmental correlates in a college sample. Am J Drug Alcohol Abuse. 2005;31(3):515-535.
34. LiMD, Burmeister M. New insights into the genetics of addiction. Nat Rev Genet. 2009;10(4): 225-231.
35. Blanco C, Rafful C,Wall MM, Ridenour TA, Wang S, Kendler KS. Towards a comprehensive developmental model of cannabis use disorders. Addiction. 2014;109(2):284-294.
36. Sugaya L, Hasin DS, Olfson M, Lin KH, Grant BF, Blanco C. Child physical abuse and adult mental health: a national study. J Trauma Stress. 2012;25 (4):384-392.
37. Verhagen M, van der Meij A, Franke B, et al. Familiality ofmajor depressive disorder and patterns of lifetime comorbidity: the NEMESIS and GenMood studies. a comparison of three samples. Eur Arch Psychiatry Clin Neurosci. 2008;258(8):505-512.
38. Blanco C, Alegria AA, Liu SM, et al. Differences among major depressive disorder with and without co-occurring substance use disorders and substance-induced depressive disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry. 2012;73 (6):865-873.
39. Magidson JF, Liu SM, Lejuez CW, Blanco C. Comparison of the course of substance use disorders among individualswith andwithout generalized anxiety disorder in a nationally representative sample. J Psychiatr Res. 2012;46(5):659-666.
40. Magidson JF,Wang S, Lejuez CW, Iza M, Blanco C. Prospective study of substance-induced and independent major depressive disorder among individuals with substance use disorders in a nationally representative sample. Depress Anxiety. 2013;30(6):538-545.
41. Khantzian EJ. The self-medication hypothesis of addictive disorders: focus on heroin and cocaine dependence.AmJ Psychiatry. 1985;142(11): 1259-1264.
42. Crum RM, Mojtabai R, Lazareck S, et al. A prospective assessment of reports of drinking to self-medicate mood symptoms with the incidence and persistence of alcohol dependence. JAMA Psychiatry. 2013;70(7):718-726.
43. Hammen C. Stress generation in depression: reflections on origins, research, and future directions. J Clin Psychol. 2006;62(9):1065-1082.
44. Kendler KS, Prescott CA. Genes, Environment and Psychopathology. New York, NY: The Guildford Press; 2006.
45. Garcia-Rodriguez O, Secades-Villa R, Florez-Salamanca L, Okuda M, Liu SM, Blanco C. Probability and predictors of relapse to smoking: results of the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). Drug Alcohol Depend. 2013;132(3):479-485.
46. Brigham GS, Schroeder G, Schindler E. Addressing smoking in community drug abuse treatment programs: practical and policy considerations. J Psychoactive Drugs. 2007;39(4): 435-441.
47. Lindsay JA, Stotts AL, Green CE, Herin DV, Schmitz JM. Cocaine dependence and concurrent marijuana use: a comparison of clinical characteristics. Am J Drug Alcohol Abuse. 2009;35 (3):193-198.
48. Nestler EJ. Common molecular and cellular substrates of addiction and memory. Neurobiol Learn Mem. 2002;78(3):637-647.
49. Bauco P, Wise RA. Potentiation of lateral hypothalamic and midlinemesencephalic brain stimulation reinforcement by nicotine: examination of repeated treatment. J Pharmacol Exp Ther. 1994;271(1):294-301.
50. Aguilar-Valles A, Vaissiere T, Griggs EM, et al. Methamphetamine-associated memory is regulated by awriter and an eraser of permissive histone methylation. Biol Psychiatry. 2014;76(1):57-65.
51. Sim-Selley LJ, Cassidy MP, Sparta A, Zachariou V, Nestler EJ, Selley DE. Effect of FosB overexpression on opioid and cannabinoid receptor-mediated signaling in the nucleus accumbens. Neuropharmacology. 2011;61(8): 1470-1476.